Dunad Therapeutics
Clinical-stage biopharmaceutical company committed to developing next-generation targeted protein degradation therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
$26—40m (Dealroom.co estimates Mar 2021.)
Company register number 12544797
Cambridge England (HQ)
Authorizing premium user...